Ming Li

机构：Qiqihar University · ORCID：0009-0001-8502-0478

发表论文 17 篇 · 总被引 164 次 · h-index 8

代表论文

• Molecular mechanism of antihistamines recognition and regulation of the histamine H1 receptor (2024 · Nature Communications · 被引 49)
• A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer (2019 · Investigational New Drugs · 被引 28)
• New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker? (2022 · Neoplasma · 被引 19)
• Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2 (2020 · Virology Journal · 被引 12)
• Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen (2023 · Journal of Cancer Research and Clinical Oncology · 被引 11)
• Decline in serum progastrin‑releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy (2020 · Oncology Letters · 被引 11)